These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6285615)

  • 21. Allosteric regulation and catalysis emerge via a common route.
    Goodey NM; Benkovic SJ
    Nat Chem Biol; 2008 Aug; 4(8):474-82. PubMed ID: 18641628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression.
    Winkler W; Nahvi A; Breaker RR
    Nature; 2002 Oct; 419(6910):952-6. PubMed ID: 12410317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Redox regulation and reaction mechanism of human cystathionine-beta-synthase: a PLP-dependent hemesensor protein.
    Banerjee R; Zou CG
    Arch Biochem Biophys; 2005 Jan; 433(1):144-56. PubMed ID: 15581573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ATP-dependent 6-phosphofructokinase from the hyperthermophilic bacterium Thermotoga maritima: characterization of an extremely thermophilic, allosterically regulated enzyme.
    Hansen T; Musfeldt M; Schönheit P
    Arch Microbiol; 2002 May; 177(5):401-9. PubMed ID: 11976749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oscillations in the phosphofructokinase-fructose 1,6-bisphosphatase cycle. I. Purification and kinetic characterization of fructose 1,6-bisphosphatase from pig liver.
    Schubert C; Schellenberger W; Eschrich K; Hofmann E
    Biomed Biochim Acta; 1983; 42(6):597-608. PubMed ID: 6314994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ATP sulfurylase from filamentous fungi: which sulfonucleotide is the true allosteric effector?
    MacRae I; Segel IH
    Arch Biochem Biophys; 1997 Jan; 337(1):17-26. PubMed ID: 8990263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ribosephosphate pyrophosphokinase activity in the thymus and liver of irradiated mice].
    Kolina VB; Kuznetsova EV; Koshcheenko NN; Romantsev EF
    Radiobiologiia; 1982; 22(4):512-6. PubMed ID: 6292992
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemical modification of allosteric properties of enzymes.
    Kemp RG
    Biol Res; 1996; 29(1):47-56. PubMed ID: 9267516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.
    Goetzman ES; Tian L; Wood PA
    Mol Genet Metab; 2005 Jan; 84(1):39-47. PubMed ID: 15639194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serine 948 and threonine 1042 are crucial residues for allosteric regulation of Escherichia coli carbamoylphosphate synthetase and illustrate coupling effects of activation and inhibition pathways.
    Delannay S; Charlier D; Tricot C; Villeret V; Piérard A; Stalon V
    J Mol Biol; 1999 Mar; 286(4):1217-28. PubMed ID: 10047492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for a catalytic Mg2+ ion and effect of phosphate on the activity of Escherichia coli phosphofructokinase-2: regulatory properties of a ribokinase family member.
    Parducci RE; Cabrera R; Baez M; Guixé V
    Biochemistry; 2006 Aug; 45(30):9291-9. PubMed ID: 16866375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human PRPS1 filaments stabilize allosteric sites to regulate activity.
    Hvorecny KL; Hargett K; Quispe JD; Kollman JM
    Nat Struct Mol Biol; 2023 Mar; 30(3):391-402. PubMed ID: 36747094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current achievements, problems and prospects in the study of hereditary enzymopathies in humans].
    Vidershaĭn GIa
    Vestn Akad Med Nauk SSSR; 1986; (10):81-8. PubMed ID: 3541441
    [No Abstract]   [Full Text] [Related]  

  • 34. Regulation of rat liver phosphofructokinase levels in Morris hepatomas.
    Dunaway GA; Leung GL; Thrasher JR; Naqui D; Morris HP
    Biochem Biophys Res Commun; 1979 Jun; 88(3):882-6. PubMed ID: 157134
    [No Abstract]   [Full Text] [Related]  

  • 35. [Myocardial dystrophy in various congenital enzymopathies].
    Odinokova VA; Paleev NR; Smirnov VB; Gurevich MA
    Sov Med; 1988; (1):34-7. PubMed ID: 3363417
    [No Abstract]   [Full Text] [Related]  

  • 36. [Spectrophotometric assay of 5-phosphoribosyl-1-pyrophosphate synthetase (PRPP) in erythrocyte lysate (author's transl)].
    Micheli V; Taddeo A
    Quad Sclavo Diagn; 1981 Jun; 17(2):209-15. PubMed ID: 6267652
    [No Abstract]   [Full Text] [Related]  

  • 37. [Congenital enzymopathies].
    Rossi E; Gautier E; Colombo JP
    Helv Med Acta; 1963 Nov; 30(4):412-27. PubMed ID: 5879106
    [No Abstract]   [Full Text] [Related]  

  • 38. [Enzymes and enzymopathies in odontology].
    Goudaert M; Danhiez P; Dufosse P
    Rev Stomatoodontol Nord Fr; 1971; 26(103):191-4. PubMed ID: 5154417
    [No Abstract]   [Full Text] [Related]  

  • 39. The theoretical analysis of kinetic behaviour of "hysteretic" allosteric enzymes. IV. Kinetics of dissociation-association processes of allosteric enzymes.
    Kurganov BI
    J Theor Biol; 1977 Oct; 68(4):521-43. PubMed ID: 21997
    [No Abstract]   [Full Text] [Related]  

  • 40. Defects in enzyme regulation versus defects in enzyme synthesis as cause of metabolic disorders.
    Belfiore F
    Enzyme; 1980; 25(2):132-7. PubMed ID: 6929752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.